Haemonetics Reports 3rd Quarter Fiscal 2016 Revenue of $233 Million, Constant Currency Revenue Growth of 4% and 1% As Reported

Go back to Haemonetics Reports 3rd Quarter Fiscal 2016 Revenue of $233 Million, Constant Currency Revenue Growth of 4% and 1% As Reported
HAEMONETICS CORPORATION (NYSE: HAE) Delayed: 103.12 +0.20 (0.19%)
Previous Close $102.92    52 Week High $39.41 
Open $101.89    52 Week Low $25.98 
Day High $103.38    P/E 145.24 
Day Low $101.25    EPS $0.71 
Volume 254,393